SGRY - Surgery Partners up 17% following Q3 earnings beat guidance increase

Shares of Surgery Partners (SGRY +17.0%) are up today following Q3 2021 earnings results that beat analyst expectations and increasing 2021 guidance. The company now expects full-year adjusted EBITDA guidance increased of $325M to $330M. It also projects 2021 revenues to increase by 19% to 21% over 2020 results. Surgery Partner's net loss also narrowed year over year by ~63% to $22.9M. Revenues increased 12.7% compared to Q3 2020 to $559.2 million. The company benefitted from a 6.2% increase in days adjusted same-facility case volume. The company ended the quarter with $330.4M in cash.

For further details see:

Surgery Partners up 17% following Q3 earnings beat, guidance increase